Retention rate of zonisamide in intractable epilepsy-Reference-Cited by-同舟云学术

Retention rate of zonisamide in intractable epilepsy

Published:2015-02-03 Issue:5 Volume:131 Page:268-274
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Nakken K. O.¹,Lindstrøm P.²,Andersen H.³

Affiliation:

1. National Centre for Epilepsy; Sandvika Norway

2. Neurological Department; Karolinska Institute; Stockholm Sweden

3. Neurological Department; Århus Hospital; Århus Denmark

Funder

Eisai

GSK

UCB

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12379/fullpdf

Reference20 articles.

1. Clinical pharmacology and mechanism of action of zonisamid;Biton;Clin Neuropharmacol,2007

2. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial;Schmidt;Epilepsy Res,1993

3. Zomisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures;Faught;Neurology,2001

4. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures;Sackellares;Epilepsia,2004

5. Dose-dependent safety and efficacy of zonisamide: a randomized, double -blind, placebo-controlled study in patients with refractory partial seizures;Brodie;Epilepsia,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-convulsant Agents: Zonisamide;NeuroPsychopharmacotherapy;2022

2. Stiripentol in the treatment of adults with focal epilepsy- a retrospective analysis;Seizure;2021-05

3. Long‐term effects of zonisamide in adult patients with intellectual disability;Acta Neurologica Scandinavica;2021-04-29

4. Anticonvulsant Agents: Zonisamide;NeuroPsychopharmacotherapy;2020

5. An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy;Expert Opinion on Pharmacotherapy;2019-03-25